Guillain-Barre Syndrome

Populations and Risk Factors

Affects all ages; slight male predominance (~1.5:1); peak incidence in adults over 50
Approximately 60–70% of cases follow a preceding infection 1–4 weeks before onset — most commonly Campylobacter jejuni gastroenteritis (strongest association), followed by cytomegalovirus, Epstein-Barr virus, Mycoplasma pneumoniae, and influenza
Post-surgical GBS occurs rarely but is documented; pregnancy (particularly postpartum) is a recognized trigger
Vaccination-associated GBS is epidemiologically rare but historically noted with the 1976 swine influenza vaccine; current risk is approximately 1–2 additional cases per million vaccinations
No genetic predisposition identified — GBS is not hereditary and does not recur in the vast majority of cases (recurrence rate ~2–5%)

Causes and Pathophysiology

Molecular Mimicry and Autoimmune Activation

The preceding infection produces antigens that structurally resemble components of the peripheral nerve myelin sheath (molecular mimicry). The immune system generates antibodies against the infection that cross-react with gangliosides on the nerve surface, initiating an autoimmune attack on the peripheral nervous system.
Macrophages infiltrate the endoneurium and strip myelin from intact axons (segmental demyelination), disrupting saltatory conduction. Nerve impulses either slow dramatically or are blocked entirely, producing the clinical paralysis.

Variants and Their Mechanisms

Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP): The most common form (~90% in North America/Europe). Primarily attacks myelin; axons are preserved initially, which is why recovery potential is high — remyelination can restore conduction.
Acute Motor Axonal Neuropathy (AMAN): Antibodies target the axonal membrane (node of Ranvier) rather than myelin. Axonal degeneration occurs. Recovery depends on axonal regeneration (~1 mm/day), making it slower and often incomplete. More common in Asia and associated with Campylobacter infection.
Acute Motor-Sensory Axonal Neuropathy (AMSAN): Both motor and sensory axons degenerate; the most severe variant with the poorest prognosis.
Miller Fisher Syndrome: Rare variant (~5%) characterized by the triad of ophthalmoplegia (eye muscle paralysis), ataxia, and areflexia without significant limb weakness. Associated with anti-GQ1b antibodies.

Clinical Progression and Recovery Sequence

Ascending pattern: Weakness typically begins in the distal lower extremities and ascends symmetrically over hours to days — feet → legs → trunk → arms → face → respiratory muscles. This ascending pattern reflects the vulnerability of the longest peripheral nerves first.
Nadir: Symptoms peak within 2–4 weeks in most patients; the plateau phase may last days to weeks before recovery begins.
Recovery sequence: Recovery is proximal-before-distal — the reverse of the onset pattern. Respiratory and trunk muscles recover first, followed by proximal limb muscles, then distal extremities. This is because shorter nerve segments remyelinate faster. Understanding this sequence is critical for MT planning: proximal muscles are available for therapeutic work before distal muscles regain function.
Residual deficits: Approximately 80% of patients can walk independently at 6 months; 60% achieve full motor recovery at 1 year. However, 15–20% have significant residual weakness (particularly distal), and 5% die from respiratory failure, autonomic dysfunction, or pulmonary embolism.

Autonomic Involvement

Autonomic nerve fibers are affected in 65–70% of cases, producing dangerous cardiovascular instability — tachycardia, bradycardia, orthostatic hypotension, hypertension, cardiac arrhythmias, and inappropriate sweating. Autonomic dysfunction is the second leading cause of death (after respiratory failure) and is a critical safety consideration for position changes in MT.

Signs and Symptoms

Acute Phase (Medical Emergency — Do Not Treat)

Rapidly progressive bilateral ascending weakness beginning in the feet and legs, spreading to the trunk, arms, and potentially face and respiratory muscles over hours to days
Areflexia — absent deep tendon reflexes throughout; the single most important neurological finding distinguishing GBS from CNS conditions
Paresthesia — bilateral tingling, numbness, and "pins and needles" beginning distally and spreading proximally; sensory symptoms are present but milder than motor deficits
Deep aching pain in the hips, pelvis, and low back — present in approximately 50–90% of patients; often precedes or accompanies the weakness and can be severe
Facial weakness (bilateral facial nerve palsy in ~50% of cases), dysphagia, dysarthria
Respiratory compromise — intercostal and diaphragmatic weakness; reduced vital capacity; one-third of patients require mechanical ventilation
Autonomic dysfunction — heart rate and blood pressure instability, flushing, excessive or absent sweating, urinary retention, ileus

Recovery Phase (MT Relevant)

Weakness resolves in a proximal-to-distal sequence — trunk and proximal limb muscles recover before hands and feet
Persistent fatigue — neurological in origin, disproportionate to apparent motor recovery; may last months to years
Residual distal weakness — foot drop, hand grip weakness, and fine motor deficits are the most common lasting impairments
Neuropathic pain — burning, tingling, or hypersensitivity in previously affected areas may persist even after motor recovery
Deconditioning — prolonged immobility during acute phase produces secondary muscle atrophy, joint stiffness, and reduced cardiovascular fitness
Psychological impact — anxiety, depression, and PTSD-like symptoms are common following the acute phase, particularly in patients who required ventilation

Assessment Profile

Subjective Presentation

Chief complaint: In recovery phase — "I still feel weak, especially in my hands and feet"; "My legs ache and feel heavy"; "I get exhausted doing things that used to be easy"; history reveals a preceding illness followed by rapidly ascending weakness that required hospitalization
Pain quality: Deep, aching muscular pain in hips and low back (common during acute and early recovery); neuropathic burning or tingling in distal extremities during recovery; pain may seem disproportionate to apparent improvement
Onset: Acute onset 1–4 weeks after a respiratory or gastrointestinal infection; weakness ascended over days; patient was hospitalized; now in recovery phase with gradual proximal-to-distal improvement
Aggravating factors: Overexertion accelerates fatigue dramatically; prolonged standing or walking worsens distal weakness and pain; cold exposure may worsen neuropathic symptoms
Easing factors: Rest improves fatigue temporarily; gentle movement prevents stiffness without inducing overexertion fatigue; warmth may ease deep muscular aching
Red flags: Any new ascending weakness or sudden worsening after initial improvement → emergency referral; possible relapse or chronic inflammatory demyelinating polyneuropathy (CIDP). Respiratory difficulty (shortness of breath, inability to count to 20 in one breath) → emergency referral; do not treat. Syncope or presyncope during position changes → autonomic instability; assist to safety and refer.

Observation

Local inspection: Visible muscle wasting most prominent in distal extremities (intrinsic hand muscles, anterior tibial compartment); foot drop may be evident; orthotic devices (ankle-foot orthosis) may be present; no skin changes specific to GBS
Posture: Compensatory posture secondary to residual weakness — forward trunk lean if hip extensors are weak; elevated shoulders if upper extremity muscles are compensating for reduced grip; posture improves as proximal muscles recover
Gait: Steppage gait if foot drop is present (high knee lift to clear toes); wide-based unsteady gait from proximal weakness and proprioceptive loss; may use assistive devices (walker, cane); fatigue visibly worsens gait quality during the session

Palpation

Tone: LMN pattern — hypotonia or flaccidity in affected muscles. No velocity-dependent resistance or clonus (distinct from UMN spasticity). Tone is most reduced distally and recovers proximally first. Recovering muscles feel weak but not spastic.
Tenderness: Deep aching tenderness in hip girdle and paraspinal muscles (nerve root inflammation at the radiculopathy level); distal neuropathic tenderness in hands and feet; trigger points in compensatory muscles — upper trapezius, cervical extensors, and contralateral limb muscles overworking to compensate for weak limbs
Temperature: Affected distal extremities may feel cool from reduced activity and impaired autonomic vasomotor control; no local warmth (GBS does not produce localized inflammation palpable at the skin); warmth is not contraindicated (unlike MS — no Uhthoff's phenomenon)
Tissue quality: Disuse atrophy — soft, reduced bulk in chronically weak muscles, especially intrinsic hand muscles and anterior tibial compartment. Deconditioning produces diffuse reduced muscle density. Fascial restrictions develop in immobilized segments during hospitalization. Pseudohypertrophy is absent (distinguishes from muscular dystrophy).

Motion Assessment

AROM: Reduced in proportion to residual weakness — proximal limb ROM recovers before distal; fatigue limits available range over the course of a session (movements that were possible at the start become difficult); no spasticity pattern (distinguishes from MS/stroke)
PROM / end-feel: End-feel is typically elastic-muscular or empty (weak muscles give way without resistance); joint restrictions may develop from prolonged immobility during acute phase — tissue stretch end-feel at ankles (plantarflexion contracture), elbows, and shoulders; PROM exceeds AROM significantly in weakened muscles (critical LMN finding)
Resisted testing: LMN-pattern weakness — graded by MMT; weakness is bilateral, symmetric, and most severe distally; proximal strength improves first during recovery; no pain on resisted testing unless secondary compensatory strain is present; fatigue causes progressive weakening during repeated testing (but not the rapid within-seconds fatigue of myasthenia gravis)

Special Test Cluster

GBS is diagnosed medically (CSF analysis, nerve conduction studies, EMG). The MT assessment cluster focuses on documenting the LMN pattern, screening for autonomic instability, and monitoring recovery progress.

Test	Positive Finding	Purpose
Deep tendon reflexes (all four limbs) (CMTO)	Hyporeflexia or areflexia — diminished or absent reflexes bilaterally	Confirm LMN lesion; the hallmark finding of GBS; distinguishes from UMN conditions (MS, stroke) where reflexes are hyperactive
Babinski sign (CMTO)	Negative (normal flexor response)	Rule out UMN pathology — a positive Babinski indicates CNS lesion (MS, stroke, cord compression), not peripheral nerve disease
Orthostatic vital signs (CMTO)	Systolic BP drop >20 mmHg or heart rate increase >30 bpm on standing	Screen for autonomic dysfunction — guides safe position changes during treatment; present in 65–70% of GBS patients
Romberg's test (supplementary)	Increased sway or loss of balance with eyes closed	Screen for proprioceptive loss from sensory nerve involvement; positive result indicates fall risk requiring session modifications
Cranial nerve screen (CN VII bilateral) (supplementary)	Bilateral facial weakness — inability to fully close eyes, asymmetric smile	Document facial nerve involvement; bilateral facial palsy is characteristic of GBS (unilateral suggests Bell's palsy)

Recovery monitoring note: Repeat DTR and resisted strength testing at each session to document recovery trajectory. Reflexes returning in proximal-to-distal sequence confirms expected recovery. Failure to improve or new deterioration warrants medical referral (possible CIDP).

Differential Diagnoses

Condition	Key Distinguishing Feature
Multiple Sclerosis	UMN signs — spasticity, hyperreflexia, positive Babinski; CNS demyelination, not peripheral; dissemination in time and space on MRI
Myasthenia Gravis	Fatigable weakness that improves with rest and worsens within seconds of repeated effort; normal reflexes; positive Tensilon test; no ascending pattern
Transverse Myelitis	Spinal cord lesion producing both UMN (below lesion) and sensory level; MRI shows cord lesion; bladder dysfunction prominent early
Poliomyelitis	Asymmetric LMN weakness (not bilateral symmetric); fever and meningeal signs at onset; no sensory involvement
Botulism	Descending paralysis (cranial nerves first, then trunk, then limbs — opposite of GBS); dilated pupils; no sensory symptoms; history of contaminated food or wound

CMTO Exam Relevance

CMTO Appendix category A4 (neurological conditions)
Hallmark triad: bilateral ascending weakness + areflexia + CSF albuminocytologic dissociation — know all three components
LMN vs. UMN distinction is the key exam differentiator: GBS produces flaccidity, hyporeflexia, and negative Babinski (LMN); MS produces spasticity, hyperreflexia, and positive Babinski (UMN) — both are demyelinating diseases but affect different divisions of the nervous system
Know the ascending-onset/proximal-first-recovery pattern — exam questions frequently test whether a student understands that recovery reverses the onset sequence
Respiratory compromise is the primary life threat — know that one-third of patients require ventilation and that forced vital capacity monitoring determines intubation
Autonomic dysfunction is the second leading cause of death — orthostatic hypotension during position changes is a practical MT safety concern that appears on practical exams
Distinguish GBS from myasthenia gravis: GBS has areflexia and ascending pattern; MG has normal reflexes and fatigable weakness worse with repetition
Know AIDP (demyelinating, good prognosis) vs. AMAN/AMSAN (axonal, poorer prognosis) — the distinction explains why some patients recover fully and others do not

Massage Therapy Considerations

Primary therapeutic target: secondary effects of prolonged immobility and deconditioning during the acute hospitalization — joint stiffness, fascial restrictions, disuse atrophy, compensatory overload patterns, and deconditioning; MT does not treat the autoimmune process itself but addresses the musculoskeletal consequences of the neurological event
Phase-dependent approach: The acute phase is a medical emergency — massage is absolutely contraindicated during active ascending paralysis. MT is indicated only during the recovery phase, once the patient has passed the nadir and is neurologically stable with improving or stable strength. Confirm with the medical team that the patient is cleared for manual therapy.
Overexertion principle — the #1 MT safety rule for GBS: Resistance training and aggressive strengthening are absolutely contraindicated as they may cause irreversible muscle deterioration in partially denervated muscles. Gentle passive and active-assisted approaches only. If the patient reports increased weakness or pain lasting more than 24 hours after a session, the treatment was too aggressive.
Autonomic instability principle: Position changes must be slow and monitored — orthostatic hypotension can cause syncope; check blood pressure before and after position changes in patients with known autonomic involvement; keep the head of the table slightly elevated if syncope risk is present
Recovery sequence guides treatment progression: Proximal muscles recover before distal muscles. Treatment progresses from proximal to distal as muscles regain function — do not attempt active or resisted work on muscles that have not yet begun to recover
Pain management: Deep aching hip and pelvic pain is common and responds to gentle massage; neuropathic distal pain requires conservative pressure and client feedback; warmth is safe and may ease muscular aching (no Uhthoff's concern as in MS)
Contraindications: active ascending phase (medical emergency); resistance training; deep pressure over atrophied muscles; aggressive stretching of flaccid muscles (risk of joint subluxation); treatment during hemodynamic instability

Treatment Plan Foundation

Clinical Goals

Maintain joint mobility and prevent contracture in immobilized or weakened segments
Reduce secondary muscle tension in compensatory overload areas (contralateral limb, cervical, trunk)
Support circulation in deconditioned extremities
Address pain — both deep muscular aching and neuropathic distal discomfort

Position

Supine or side-lying preferred — side-lying allows access to posterior trunk without requiring prone positioning, which may be difficult for patients with residual trunk weakness
Position changes must be slow and assisted — monitor for orthostatic symptoms (dizziness, lightheadedness, visual changes) with every transition
Bolstering under weakened limbs to maintain neutral joint alignment and prevent dependent edema
If foot drop is present, support feet in neutral dorsiflexion to prevent plantarflexion contracture reinforcement

Session Sequence

General effleurage to posterior trunk — assess overall tone, identify compensatory tension patterns, and establish tissue baseline; note areas of disuse atrophy vs. compensatory hypertonia
Myofascial release to thoracolumbar fascia and hip girdle — address fascial restrictions from prolonged bed rest; gentle sustained technique within pain-free tolerance
Sustained compression and gentle stripping of hip girdle muscles (gluteals, piriformis, hip rotators) — target the deep aching pain reported in hips and pelvis; these muscles are a primary pain source in GBS recovery
Gentle effleurage and petrissage to proximal lower extremities (quadriceps, hamstrings) — support circulation and reduce deconditioning stiffness; work only muscles that have begun to show recovery (MMT grade 2+)
Compensatory pattern work — upper trapezius, cervical extensors, and upper extremity muscles overloaded from assistive device use (crutches, walker handles); trigger point release as indicated
Gentle passive ROM to ankles and feet [only if distal recovery has begun] — maintain joint mobility and prevent plantarflexion contracture; slow, sustained stretching within available range; do not force range in flaccid muscles
Light effleurage to distal extremities — promote circulation; conservative pressure in areas of neuropathic sensitivity; monitor client feedback carefully as sensation may be altered

Adjunct Modalities

Hydrotherapy: Moist heat to hip girdle and paraspinal muscles pre-treatment to ease deep muscular aching and improve tissue pliability; warmth is safe in GBS (no Uhthoff's concern); cool applications are not indicated unless the patient reports post-treatment soreness; avoid extreme temperatures in areas of impaired autonomic thermoregulation
Joint mobilization: Gentle passive mobilization of ankles (dorsiflexion), wrists, and fingers to maintain joint play and prevent contracture from immobility; performed after soft tissue release; Grade I–II only in weakened segments; do not mobilize joints with subluxation risk from flaccid surrounding muscles
Remedial exercise (on-table): Active-assisted ROM through available range in recovering muscles — therapist supports the limb while the client moves through their available range; purpose is to maintain mobility and provide proprioceptive input without overexertion; no resisted strengthening — resistance training is contraindicated in partially denervated muscles and may cause irreversible deterioration

Exam Station Notes

Demonstrate awareness that GBS acute phase is a medical emergency and that MT is only appropriate during the recovery phase — state this explicitly
Monitor for and verbalize autonomic instability — slow position changes, check for dizziness, keep head elevated if needed
Demonstrate the LMN assessment: test DTRs (expect hyporeflexia/areflexia), test Babinski (expect negative), note flaccidity not spasticity
Show session pacing — acknowledge that neurological fatigue requires shorter sessions and willingness to stop if the client fatigues

Verbal Notes

Autonomic warning: before every position change — "I'm going to help you roll to your side now. We'll do it slowly. If you feel dizzy, lightheaded, or your vision changes, tell me immediately and we'll pause."
Overexertion education: at session start — "This should feel gentle and comfortable. If you notice your weakness getting worse after our session, or if the fatigue lasts more than a day, that tells me we did too much. I need you to let me know so I can adjust next time."
Altered sensation: before working distal extremities — "I know the feeling in your hands/feet has been different. I'm going to start with very light pressure. Tell me what you feel — too much, too little, or any burning or tingling."
Post-treatment fatigue: advise rest for the remainder of the day; do not schedule demanding activities after treatment

Self-Care

Gentle daily active ROM within pain-free range — focus on ankles (dorsiflexion to prevent plantarflexion contracture), wrists, and fingers; stop if fatigue increases
Activity pacing — alternate activity with rest; avoid sustained exertion; the "50% rule" (stop at 50% of perceived capacity) prevents overexertion damage to recovering nerves
Positioning at rest — keep feet at 90 degrees (use a footboard or pillow against the soles) to prevent equinus contracture; elevate legs if dependent edema is present
Monitor and report any new weakness, increased numbness, or breathing difficulty to the medical team — these may indicate relapse or transition to CIDP

Key Takeaways

GBS is an acute autoimmune peripheral nerve demyelination producing LMN signs — flaccidity, areflexia, negative Babinski — the opposite of the UMN pattern seen in MS
The hallmark clinical triad is bilateral ascending weakness, areflexia, and CSF albuminocytologic dissociation
The acute phase is a medical emergency; one-third of patients require mechanical ventilation; massage is absolutely contraindicated until the recovery phase
Recovery follows a proximal-before-distal sequence (the reverse of onset) because shorter nerve segments remyelinate faster
Resistance training is absolutely contraindicated as it may cause irreversible muscle deterioration in partially denervated muscles — gentle passive and active-assisted approaches only
Autonomic dysfunction (orthostatic hypotension, cardiac instability) occurs in 65–70% of patients and governs safe position changes during treatment
Distinguish from myasthenia gravis (normal reflexes, fatigable weakness, no ascending pattern) and from MS (UMN signs, CNS lesion, chronic course)